0ACT Stock Overview
Develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
AlzChem Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €54.40 |
| 52 Week High | €55.40 |
| 52 Week Low | €22.60 |
| Beta | 1.01 |
| 11 Month Change | 25.06% |
| 3 Month Change | 11.93% |
| 1 Year Change | n/a |
| 33 Year Change | 118.47% |
| 5 Year Change | 189.36% |
| Change since IPO | 164.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0ACT | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 5.4% | -3.6% | -0.5% |
| 1Y | n/a | -8.0% | 7.7% |
Return vs Industry: Insufficient data to determine how 0ACT performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how 0ACT performed against the UK Market.
Price Volatility
| 0ACT volatility | |
|---|---|
| 0ACT Average Weekly Movement | 7.3% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0ACT's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0ACT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1908 | 1,607 | Andreas Niedermaier | www.alzchem.com |
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.
AlzChem Group AG Fundamentals Summary
| 0ACT fundamental statistics | |
|---|---|
| Market cap | €549.52m |
| Earnings (TTM) | €46.34m |
| Revenue (TTM) | €556.77m |
11.9x
P/E Ratio1.0x
P/S RatioIs 0ACT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0ACT income statement (TTM) | |
|---|---|
| Revenue | €556.77m |
| Cost of Revenue | €218.93m |
| Gross Profit | €337.84m |
| Other Expenses | €291.50m |
| Earnings | €46.34m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 4.55 |
| Gross Margin | 60.68% |
| Net Profit Margin | 8.32% |
| Debt/Equity Ratio | 29.3% |
How did 0ACT perform over the long term?
See historical performance and comparison